Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 55 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Trevena Inc | TRVN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.3996 | 08:41:50 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.3996 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 5 | 55 | - | 0.3001 - 1.12 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:21:20 | 40 | $ 0.3826 | USD |
Trevena Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.33M | 18.32M | - | 3.13M | -40.29M | -2.20 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Trevena News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TRVN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.396 | 0.4369 | 0.38265 | 0.4063061 | 54,258 | 0.0036 | 0.91% |
| 1 Month | 0.4188 | 0.4397 | 0.38 | 0.4069158 | 53,684 | -0.0192 | -4.58% |
| 3 Months | 0.558 | 0.568 | 0.3001 | 0.4061678 | 182,142 | -0.1584 | -28.39% |
| 6 Months | 0.629 | 0.7693 | 0.3001 | 0.4955102 | 144,675 | -0.2294 | -36.47% |
| 1 Year | 1.04 | 1.12 | 0.3001 | 0.7668982 | 321,652 | -0.6404 | -61.58% |
| 3 Years | 50.00 | 55.00 | 0.3001 | 14.00 | 1,030,216 | -49.60 | -99.20% |
| 5 Years | 26.00 | 112.50 | 0.3001 | 40.04 | 1,909,003 | -25.60 | -98.46% |
Trevena Description
| Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain. |
